Compare VKTX & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VKTX | NMRK |
|---|---|---|
| Founded | 2012 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.8B |
| IPO Year | 2014 | 2017 |
| Metric | VKTX | NMRK |
|---|---|---|
| Price | $29.62 | $13.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $95.86 | $18.75 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.76% |
| EPS Growth | N/A | ★ 100.00 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $3,294,024,000.00 |
| Revenue This Year | N/A | $12.45 |
| Revenue Next Year | N/A | $8.02 |
| P/E Ratio | ★ N/A | $180.25 |
| Revenue Growth | N/A | ★ 20.29 |
| 52 Week Low | $22.96 | $11.02 |
| 52 Week High | $43.15 | $19.84 |
| Indicator | VKTX | NMRK |
|---|---|---|
| Relative Strength Index (RSI) | 42.62 | 37.74 |
| Support Level | $29.32 | $13.68 |
| Resistance Level | $36.77 | $15.09 |
| Average True Range (ATR) | 1.25 | 0.59 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 31.20 | 14.29 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.